Skip to main content

Cardiol Therapeutics(CRDL-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low1.3100
Day High1.4000
Open:1.3700
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Newswire.ca
Cardiol Therapeutics to Participate in Fireside Chat at H.C. Wainwright 4th Annual BioConnect Investor Conference at the NASDAQ
Tipranks
Analysts Offer Insights on Healthcare Companies: Cardiol Therapeutics (CRDL) and BridgeBio Pharma (BBIO)
Tipranks
Cardiol Therapeutics Reports Higher Q1 2026 Loss but Stronger Cash Position
Tipranks
Cardiol Therapeutics’ Phase II MAvERIC Pericarditis Data Accepted by JAHA as Phase III Trial Nears Completion
Newswire.ca
Cardiol Therapeutics' Phase II MAvERIC Results Accepted for Publication in the Journal of the American Heart Association
Newswire.ca
Cardiol Therapeutics Expands U.S. MAVERIC Phase III Trial Network to Address Growing Interest in the Pivotal Program
Tipranks
Cardiol Therapeutics Showcases MAVERIC Phase III Trial and ARCHER Results in Barchart Live Interview
Newsfile
Cardiol Therapeutics to Highlight MAVERIC Phase III Trial and Recently Published ARCHER Results in Live Interview with Barchart
Tipranks
Cardiol Therapeutics Sets June 24, 2026 Date for Annual General Meeting of Shareholders
Tipranks
Wall Street Analysts Are Bullish on Top Healthcare Picks
Tipranks
Analysts Offer Insights on Healthcare Companies: Neurogene (NGNE), Alzamend Neuro (ALZN) and Cardiol Therapeutics (CRDL)
Tipranks
Analysts Offer Insights on Healthcare Companies: Cardiol Therapeutics (CRDL), Annexon Biosciences (ANNX) and VolitionRX (VNRX)
Tipranks
Cardiol Therapeutics Details 2025 Progress and Funding for Late-Stage Cardiac Drug Programs
Newsfile
Cardiol Therapeutics Announces Year-End 2025 Update on Operations
Zacks Investment Research
Pharming Group Gears Up to Report Q4 Earnings: What's in the Cards?
Pharming Group Gears Up to Report Q4 Earnings: What's in the Cards?
Tipranks
Cardiol Therapeutics to Present Cardiovascular Pipeline Update at TD Cowen Health Care Conference
Newsfile
Cardiol Therapeutics to Present at TD Cowen 46th Annual Health Care Conference
Tipranks
Analysts Offer Insights on Healthcare Companies: Cardiol Therapeutics (CRDL) and Centene (CNC)
Tipranks
Cardiol Therapeutics’ ARCHER Phase II Myocarditis Data Published in ESC Heart Failure

Profile

Cardiol Therapeutics Inc. is a clinical-stage biotechnology company. It focused on developing innovative anti-inflammatory therapies for the treatment of cardiovascular disease. The company's lead product consist CardiolRx(TM). Cardiol Therapeutics Inc. is based in Oakville, ON.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.